MX2010007353A - Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. - Google Patents

Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.

Info

Publication number
MX2010007353A
MX2010007353A MX2010007353A MX2010007353A MX2010007353A MX 2010007353 A MX2010007353 A MX 2010007353A MX 2010007353 A MX2010007353 A MX 2010007353A MX 2010007353 A MX2010007353 A MX 2010007353A MX 2010007353 A MX2010007353 A MX 2010007353A
Authority
MX
Mexico
Prior art keywords
group
pyrroine
carboxamid
imidazo
heterocyclic
Prior art date
Application number
MX2010007353A
Other languages
English (en)
Inventor
Jean-Francois Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2010007353A publication Critical patent/MX2010007353A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Abstract

Compuestos de fórmula (I) en donde X representa un grupo fenilo opcionalmente sustituido; R1 representa un átomo de hidrógeno, un halógeno, un grupo alcoxi de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono, un grupo NRaRb; R2 es un grupo heterocíclico opcionalmente sustituido; R3 representa un átomo de hidrógeno, un grupo alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono o un átomo de halógeno; R4 representa un átomo de hidrógeno, un grupo alquilo de 1 a 4 átomos de carbono, alcoxi de 1 a 4 átomos de carbono o un átomo de flúor, en la forma de base o de sal de adición con un ácido. Uso terapéutico.
MX2010007353A 2008-01-02 2008-12-31 Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. MX2010007353A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800005A FR2925903B1 (fr) 2008-01-02 2008-01-02 DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001836 WO2009106750A2 (fr) 2008-01-02 2008-12-31 Dérivés 6-heterocyclique-imidazo[1,2-a]pyrroine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
MX2010007353A true MX2010007353A (es) 2010-08-18

Family

ID=39745373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007353A MX2010007353A (es) 2008-01-02 2008-12-31 Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.

Country Status (25)

Country Link
US (2) US8314109B2 (es)
EP (1) EP2225240B1 (es)
JP (1) JP5258899B2 (es)
KR (1) KR101600635B1 (es)
CN (1) CN101959884B (es)
AR (1) AR070074A1 (es)
AU (1) AU2008351928B2 (es)
BR (1) BRPI0821458A2 (es)
CA (1) CA2710947C (es)
CL (1) CL2008003928A1 (es)
CO (1) CO6331309A2 (es)
EA (1) EA019122B1 (es)
FR (1) FR2925903B1 (es)
HK (1) HK1148016A1 (es)
IL (1) IL206669A (es)
MA (1) MA32527B1 (es)
ME (1) ME01157B (es)
MX (1) MX2010007353A (es)
MY (1) MY155468A (es)
NZ (1) NZ586474A (es)
SG (1) SG187408A1 (es)
TW (1) TWI432432B (es)
UY (1) UY31589A1 (es)
WO (1) WO2009106750A2 (es)
ZA (1) ZA201004644B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EA201490807A1 (ru) * 2011-10-21 2014-07-30 Торрент Фармасьютикалз Лимитед Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1
CN104884424B (zh) 2012-12-25 2016-08-24 日本曹达株式会社 卤代苯胺及其制造方法
CN108295074B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种噻二唑并三嗪类化合物在制备单胺氧化酶抑制剂中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
US20060233771A1 (en) * 2002-09-24 2006-10-19 Ernesto Arenas Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
US7405299B2 (en) * 2002-11-27 2008-07-29 Eli Lilly And Company Compounds as pharmaceutical agents
WO2004103991A1 (fr) * 2003-05-20 2004-12-02 'chemical Diversity Research Institute', Ltd. Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
FR2903108B1 (fr) * 2006-07-03 2008-08-29 Sanofi Aventis Sa Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903106B1 (fr) * 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique

Also Published As

Publication number Publication date
AR070074A1 (es) 2010-03-10
US20130041152A1 (en) 2013-02-14
US20100317675A1 (en) 2010-12-16
BRPI0821458A2 (pt) 2015-06-16
WO2009106750A2 (fr) 2009-09-03
IL206669A (en) 2015-07-30
EP2225240A2 (fr) 2010-09-08
FR2925903A1 (fr) 2009-07-03
MY155468A (en) 2015-10-15
EA201070814A1 (ru) 2011-02-28
FR2925903B1 (fr) 2011-01-21
IL206669A0 (en) 2010-12-30
JP2011508760A (ja) 2011-03-17
UY31589A1 (es) 2009-08-03
MA32527B1 (fr) 2011-08-01
US8314109B2 (en) 2012-11-20
CO6331309A2 (es) 2011-10-20
TWI432432B (zh) 2014-04-01
EA019122B1 (ru) 2014-01-30
SG187408A1 (en) 2013-02-28
KR20100109940A (ko) 2010-10-11
ME01157B (me) 2013-03-20
EP2225240B1 (fr) 2014-01-22
KR101600635B1 (ko) 2016-03-07
AU2008351928B2 (en) 2013-11-21
ZA201004644B (en) 2011-11-30
HK1148016A1 (es) 2011-08-26
WO2009106750A3 (fr) 2010-02-25
CL2008003928A1 (es) 2010-02-12
CN101959884B (zh) 2013-02-27
CA2710947A1 (fr) 2009-09-03
CN101959884A (zh) 2011-01-26
US8691990B2 (en) 2014-04-08
JP5258899B2 (ja) 2013-08-07
NZ586474A (en) 2012-06-29
TW200934780A (en) 2009-08-16
CA2710947C (fr) 2016-04-12
AU2008351928A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
MY145603A (en) 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
MX344669B (es) Agente antiplaquetas novedoso.
WO2009156861A8 (en) Substituted pyrimidone derivatives
MX2011012059A (es) Derivados de ciclopenta [c] pirrol-2-carboxilatos, su preparación y su uso en terapeutica.
MA32247B1 (fr) Derives de 2-aryl-6-phenyl-imidazo[1,2-a]pyridines polysubstitues, leur préparation et leur application en thérapeutique
MY177250A (en) Novel nicotinamide derivative or salt thereof
WO2008136444A1 (ja) 縮合複素環誘導体
WO2008003854A3 (fr) Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
MX2011012057A (es) Derivados de ciclopenta [c] pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su uso en terapéutica.
WO2009156864A3 (en) Substituted alkyl pyrimidin-4-one derivatives
EA201170093A1 (ru) Замещенные n-оксидпиразиновые производные
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
MX2010007351A (es) Derivados de imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica.
CO6351789A2 (es) Derivados de carbamatos de alquiltiazoles, su preparacion y su aplicacion en terapeutica
IN2012DN00770A (es)
MX2010007349A (es) Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.
MX2010007353A (es) Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.
MY146939A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
IN2012DN00768A (es)
WO2008003855A3 (fr) Utilisation de 2-benzoyl-imidazopyridines en thérapeutique
MX2010007352A (es) Derivados de n-heterociclico-6-heterociclico-imidazo[1,2-a]piridin a-2-carboxamidas, su preparacion y su aplicacion terapeutica.
WO2008003858A3 (fr) Utilisation de dérivés d'imidazo[1, 2-a]pyridine-2-carboxamides en thérapeutique
MX2010007348A (es) Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion terapeutica.
EA201070819A1 (ru) Соединения n-фенилимидазо[1,2-a]пиридин-2-карбоксамида, их получение и их применени в терапии

Legal Events

Date Code Title Description
FG Grant or registration